Abstract
Purpose
To systematically assess the efficacy and side effects of scalp cooling in patients with breast cancer.
Methods
A systematic literature search was conducted in October 2020 across Cochrane Library, PubMed, Embase, CINAHL, Web of Science, Scopus, and four Chinese databases (CNKI, Wanfang, SinoMed, and VIP database). Our review included all randomized controlled trials, cohort studies, and cross-sectional studies. Two authors independently searched databases, screened studies, extracted data, and evaluated each included study’s methodological quality and risk bias. Meta-analysis was performed using Stata 15.1 software package and Revman 5.3 software, with estimates of scalp cooling effect and its side effects from pooled using a random-effects model. This study has been registered in the International Prospective Register of Systematic Reviews (PROSPERO, CRD42020216224).
Results
In total, 755 articles were screened and data from 27 studies involving 2202 participants were used in the meta-analysis. Studies meeting inclusion and exclusion criteria were three randomized clinical trials, 12 cohort studies, and 12 cross-sectional studies. The effectiveness rate of using a scalp cooling device to protect hair was 61% (95% CI: 55 to 67%, I2 = 88%, P = 0.000). However, scalp cooling therapy’s side effects are not be ignored, such as headache, dizziness, scalp pain, neck pain, feeling cold, heaviness of the head, skin rash, nausea, and overtightened strap.
Conclusions
This review shows that scalp cooling devices can significantly improve the patients with breast cancer chemotherapy–induced alopecia, but the implications of its side effects provide guide for the implementation of this technology.
Similar content being viewed by others
Data availability
Not applicable; no person’s data.
References
Freddie B, Jacques F, Isabelle S et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424
Hesketh Paul J (2004) Batchelor Diane, Golant Mitch et al. Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches. Support Care Cancer 12:543–549
Yeager Caroline E, Olsen Elise A (2011) Treatment of chemotherapy-induced alopecia. Dermatol Ther 24:432–442
Macquart-Moulin G, Viens P, Bouscary ML, Genre D, Resbeut M, Gravis G, Camerlo J, Maraninchi D, Moatti JP (1997) Discordance between physicians’ estimations and breast cancer patients’ self-assessment of side-effects of chemotherapy: an issue for quality of care. Br J Cancer 76:1640–1645
Dean JC, Salmon SE, Griffith KS (1979) Prevention of doxorubicin-induced hair loss with scalp hypothermia. N Engl J Med 301:1427–1429
Batchelor D (2001) Hair and cancer chemotherapy: consequences and nursing care--a literature study. Eur J Cancer Care (Engl) 10:147–163
Kyung CE, Im-Ryung K, Oliver C et al (2014) Impact of chemotherapy-induced alopecia distress on body image, psychosocial well-being, and depression in breast cancer patients. Psychooncology 23:1103–1110
Arlene C, Astrid B, Sally P et al (2018) Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimens. Breast 41:127–132
Julie L, Elizabeth M, Louise P (2008) Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review. Psychooncology 17:317–328
Julie L, Carl A, Louise P et al (2009) Incidence of scalp metastases in breast cancer: a retrospective cohort study in women who were offered scalp cooling. Breast Cancer Res Treat 118:547–552
Rugo Hope S, Jeffrey V (2018) Scalp hypothermia for preventing alopecia during chemotherapy. A systematic review and meta-analysis of randomized controlled trials. Clin Breast Cancer 18:19–28
Shah VV, Wikramanayake TC, DelCanto GM, van den Hurk C, Wu S, Lacouture ME, Jimenez JJ (2018) Scalp hypothermia as a preventative measure for chemotherapy-induced alopecia: a review of controlled clinical trials. J Eur Acad Dermatol Venereol 32:720–734
Hyoseung S, Jin JS, Do Hun K et al (2015) Efficacy of interventions for prevention of chemotherapy-induced alopecia: a systematic review and meta-analysis. Int J Cancer 136:E442–E454
Christel P, Katrin E, Jacques C et al (2002) Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy. Support Care Cancer 10:529–537
Massey Carolyn S (2004) A multicentre study to determine the efficacy and patient acceptability of the Paxman Scalp Cooler to prevent hair loss in patients receiving chemotherapy. Eur J Oncol Nurs 8:121–130
van den Hurk CJ, Mijke P, van de Poll-Franse Lonneke V et al (2012) Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - results of the Dutch Scalp Cooling Registry. Acta Oncol 51:497–504
Komen Manon MC, van den Hurk CJG, Nortier Johan WR et al (2019) Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy. Support Care Cancer 27:1919–1925
Rugo Hope S, Paula K, Anitra MS et al (2017) Association between use of a scalp cooling device and alopecia after chemotherapy for breast cancer. JAMA 317:606–614
Julie N, Wang T, Cynthia O et al (2017) Effect of a scalp cooling device on alopecia in women undergoing chemotherapy for breast cancer: the SCALP randomized clinical trial. JAMA 317:596–605
C. MACDUFF, T. MACKENZIE, A. HUTCHEON, L. MELVILLE, H. ARCHIBALD, (2003) The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel. European Journal of Cancer Care 12 (2):154-161
Marzieh K (2011) Sarvestani Raheleh Sabet, Khojasteh Habib Noorani et al. Efficacy of penguin cap as scalp cooling system for prevention of alopecia in patients undergoing chemotherapy. J Adv Nurs 67:2473–2477
Betticher Daniel C (2013) Delmore Geoffrey, Breitenstein Urs et al. Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment. Support Care Cancer 21:2565–2573
Peck HJ, Mitchell H, Stewart AL (2000) Evaluating the efficacy of scalp cooling using the Penguin cold cap system to reduce alopecia in patients undergoing chemotherapy for breast cancer. Eur J Oncol Nurs 4:246–248
Robinson MH, Jones AC, Durrant KD (1987) Effectiveness of scalp cooling in reducing alopecia caused by epirubicin treatment of advanced breast cancer. Cancer Treat Rep 71:913–914
Kay F, Carstensen Martin H (2014) Successful reduction of alopecia induced by anthracycline and taxane containing adjuvant chemotherapy in breast cancer—clinical evaluation of sensor-controlled scalp cooling. Springerplus 3:500
Giaccone G, Di Giulio F, Morandini MP et al (1988) Scalp hypothermia in the prevention of doxorubicin-induced hair loss. Cancer Nurs 11:170–173
Macduff C, Mackenzie T, Hutcheon A et al (2003) The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel. Eur J Cancer Care (Engl) 12:154–161
Rostom A, Dube C, Cranney A, et al. Celiac disease. Rockville (MD): Agency for Healthcare Research and Quality (US); 2004Sep. (Evidence Reports/Technology Assessments, No.104.) Appendix D. Quality Assessment Forms. http://www.ncbi.nlm.nih.gov/books/NBK35156.
Andreas S (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605
Cochrane handbook for systematic reviews of interventions version5.1.0[EB/OL]. http://handbook.cochrane.org.
Higgins Julian PT, Thompson Simon G, Deeks Jonathan J et al (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560
Emilia G, Giorgia R, Manuela B et al (2019) Scalp cooling in daily clinical practice for breast cancer patients undergoing curative chemotherapy: a multicenter interventional study. Asia Pac J Oncol Nurs 6:277–282
Tessa C, Devora I, Barbara F et al (2015) Efficacy of scalp cooling in preventing chemotherapy-induced alopecia in breast cancer patients receiving adjuvant docetaxel and cyclophosphamide chemotherapy. Clin Breast Cancer 15:332–334
Tiziana P, Alessandra H, Federica A et al (2019) Hair loss prevention by a scalp cooling device in early breast cancer patients: the Poliambulanza preliminary experience. Rev Recent Clin Trials 14:66–71
Laura O, Dario L, Palma F et al (2019) Final results of a prospective study of scalp cooling in preventing chemotherapy-induced alopecia. Future Oncol 15:3337–3344
Marniza S, Tze CFL, Zarina BA et al (2018) The efficacy and tolerability of scalp cooling in preventing chemotherapy-induced alopecia in patients with breast cancer receiving anthracycline and taxane-based chemotherapy in an Asian setting. Indian J Cancer 55:157–161
Elisabetta M, Vincenzo B, Giuseppe C et al (2019) Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines. Br J Cancer 121:325–331
Rebecca P, Carla F, di Mauro P et al (2020) Efficacy of the DigniCap System in preventing chemotherapy-induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device. Int J Nurs Pract undefined:e12888.
Katharina S, Philippe J, Manuel F et al (2019) COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer. Breast Cancer Res Treat 173:135–143
Dörthe S-N, Inge S, Anke J-N et al (2015) The influence of various parameters on the success of sensor-controlled scalp cooling in preventing chemotherapy-induced alopecia. Oncol Res Treat 38:489–495
Ines V, Alexandra W, Winfried S (2018) Scalp cooling successfully prevents alopecia in breast cancer patients undergoing anthracycline/taxane-based chemotherapy. Breast 40:1–3
van den Hurk CJG, Floortje M, Vingerhoets Ad JJM et al (2010) Impact of alopecia and scalp cooling on the well-being of breast cancer patients. Psychooncology 19:701–709
Floortje M, van den Hurk CJ, Vingerhoets Ad JJM et al (2009) Scalp cooling to prevent chemotherapy-induced hair loss: practical and clinical considerations. Support Care Cancer 17:181–189
Ron IG, Kalmus Y, Kalmus Z, Inbar M, Chaitchik S (1997) Scalp cooling in the prevention of alopecia in patients receiving depilating chemotherapy. Support Care Cancer 5:136–138
Li Y, Fengli LU, Dongsheng Z (2017) Study on scalp cooling therapy for prevention of hair loss in patients with breast cancer chemotherapy and its influencing factors. Nurs Res 31(18):2244–2246
Bajpai J, Kagwade S, Chandrasekharan A, Dandekar S, Kanan S, Kembhavi Y, Ghosh J, Banavali SD, Gupta S (2020) Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia. Breast 49:187–193
Takayuki K, Takahiro N, Eisuke F et al (2019) Efficacy of scalp cooling in preventing and recovering from chemotherapy-induced alopecia in breast cancer patients: the HOPE study. Front Oncol 9:733
Franz-Ferdinand Bitto, Alexander König, Thuy Phan-Brehm, Thomas Vallbracht, Julian Gregor Koch, Timo Schinköthe, Matthias Wolfgarten, Sven Mahner, Nadia Harbeck, Rachel Würstlein, (2020) EVA-Scalp: Evaluation of Patient Satisfaction with a Scalp Cooling Device to Prevent Chemotherapy-Induced Alopecia in Breast Cancer Patients. Breast Care 15 (2):171-177
Fan C, Liang Y, Dawei Z et al (2018) Application of scalp cooling cap to reduce alopecia in breast cancer patients with neoadjuvant chemotherapy. Chin J Mammary Gland Diseas 12(06):340–345
Tommaso G, Simona F, Monica Z et al (2020) Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: a prospective study. Breast J 26:1296–1301
Shozo O, Sachiko K, Mina T et al (2021) Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy. Support Care Cancer 29:437–443
Rice Brooke A (2018) Ver Hoeve Elizabeth S, DeLuca Amy N et al. Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat 167:117–122
Mustoe Mollie M, Lee Carmen M, Melisko Michelle E et al (2018) The DigniCap Scalp Cooling System and its use in the treatment of chemotherapy-induced alopecia. Future Oncol 14:2461–2469
Mikel R, Erica F-C (2017) Scalp cooling: a literature review of efficacy, safety, and tolerability for chemotherapy-induced alopecia. Clin J Oncol Nurs 21:226–233
Martín M, de la Torre-Montero JC, López-Tarruella S, Pinilla K, Casado A, Fernandez S, Jerez Y, Puente J, Palomero I, González del Val R, del Monte-Millan M, Massarrah T, Vila C, García-Paredes B, García-Sáenz JA, Lluch A (2018) Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling. Breast Cancer Res Treat 171:627–634
Jung-Woo C, Raymond N, Alexandre C (2018) Chemotherapy drug concentrations in hair follicles: a potential biomarker to monitor the effectiveness of scalp cooling for chemotherapy-induced alopecia. Support Care Cancer 26:3669–3670
Megan K, Jame A (2018) Management of chemotherapy-induced alopecia with scalp cooling. J Oncol Pract 14:149–154
Kaarina AP, Annikki MU, Marika SK et al (2010) The effectiveness of a scalp cooling cap in preventing chemotherapy-induced alopecia. Tumori 96:271–275
Mona R, Maria B, Anita G (2003) Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients. Support Care Cancer 11:371–377
Gulbeyaz C, Melike D, Ozgul E et al (2013) A comparison of men and women’s experiences of chemotherapy-induced alopecia. Eur J Oncol Nurs 17:255–260
Azael F-M, Jerry S, Shari G et al (2019) Hair disorders in patients with cancer. J Am Acad Dermatol 80:1179–1196
Bülow J, Friberg L, Gaardsting O, Hansen M (1985) Frontal subcutaneous blood flow, and epi- and subcutaneous temperatures during scalp cooling in normal man. Scand J Clin Lab Invest 45:505–508
Christodoulou C, Tsakalos G, Galani E, Skarlos DV (2006) Scalp metastases and scalp cooling for chemotherapy-induced alopecia prevention. Ann Oncol 17:350
Gregory RP, Cooke T, Middleton J et al (1982) Prevention of doxorubicin-induced alopedia by scalp hypothermia: relation to degree of cooling. Br Med J (Clin Res Ed) 284:1674
Komen MMC, Smorenburg CH, Nortier JWR, van der Ploeg T, van den Hurk CJG, van der Hoeven JJM (2016) Results of scalp cooling during anthracycline containing chemotherapy depend on scalp skin temperature. Breast 30:105–110
Rugo Hope S, Melin Susan A (2017) Voigt Jeff, Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis. Breast Cancer Res Treat 163:199–205
Code availability
Stata 15.1 software package (Stata Corp LP, College Station, TX, USA.) and Revman 5.3 software (The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.)
Author information
Authors and Affiliations
Contributions
The conception and design of the review: all authors
Literature retrieval: SW, TY
Literature screening: SW, TY, AS
Quality assessment: SW, TY, AS
Data analysis: SW, WQ, ZZ, FZ
Writing—original draft: SW
Writing—review and editing: all authors
Corresponding author
Ethics declarations
Ethics approval
As this is a systematic review reporting on existing data, ethics approval was not required.
Consent to participate
This article does not contain any studies with human participants or animals performed by any of the authors.
Consent to publish
The authors are responsible for the correctness of the statements provided in the manuscript. There was no need to obtain permission from any person for publication of this review.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
ESM 1
(DOCX 36 kb)
Rights and permissions
About this article
Cite this article
Wang, S., Yang, T., Shen, A. et al. The scalp cooling therapy for hair loss in breast cancer patients undergoing chemotherapy: a systematic review and meta-analysis. Support Care Cancer 29, 6943–6956 (2021). https://doi.org/10.1007/s00520-021-06188-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-021-06188-8